PCH
VIVO

Polar Capital Holdings’s Meridian Bioscience Inc VIVO Stock Holding History

Polar Capital Holdings’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,718
Closed -$448 – 457
2022
Q2 		$448 Sell
14,718
-6,917
-32% -$187K ﹤0.01% 346
2022
Q1 		$562 Sell
21,635
-11,828
-35% -$281K ﹤0.01% 371
2021
Q4 		$683 Buy
33,463
+1,300
+4% +$24.9K ﹤0.01% 364
2021
Q3 		$619 Sell
32,163
-8,072
-20% -$161K ﹤0.01% 332
2021
Q2 		$892 Hold
40,235
– – ﹤0.01% 324
2021
Q1 		$1.06M Buy
40,235
+9,998
+33% +$238K 0.01% 290
2020
Q4 		$565K Buy
+30,237
New +$565K ﹤0.01% 305

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Polar Capital Holdings's VIVO Position: Q3 2022 in Review

Polar Capital Holdings sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 14,718 shares — an estimated $448 sold.

Polar Capital Holdings first reported a position in VIVO in Q4 2020 and held it in 7 quarters. The position peaked at $1.06M in Q1 2021. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Polar Capital Holdings reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Polar Capital Holdings sold 14,718 Meridian Bioscience Inc shares in Q3 2022, an estimated $448.
  • Polar Capital Holdings first reported a position in Meridian Bioscience Inc in Q4 2020 and held it in 7 quarters.
  • Polar Capital Holdings's Meridian Bioscience Inc position peaked at $1.06M in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.